WO2023023813A1 - Amélioration apportée à des formulations de concentré en suspension - Google Patents
Amélioration apportée à des formulations de concentré en suspension Download PDFInfo
- Publication number
- WO2023023813A1 WO2023023813A1 PCT/AU2022/051041 AU2022051041W WO2023023813A1 WO 2023023813 A1 WO2023023813 A1 WO 2023023813A1 AU 2022051041 W AU2022051041 W AU 2022051041W WO 2023023813 A1 WO2023023813 A1 WO 2023023813A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formulation
- epoxiconazole
- particle size
- size distribution
- less
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 62
- 238000009472 formulation Methods 0.000 title claims abstract description 60
- 239000004546 suspension concentrate Substances 0.000 title description 29
- 230000006872 improvement Effects 0.000 title description 3
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 claims abstract description 30
- 239000005767 Epoxiconazole Substances 0.000 claims abstract description 30
- 239000002245 particle Substances 0.000 claims abstract description 26
- 238000009826 distribution Methods 0.000 claims abstract description 17
- 239000004480 active ingredient Substances 0.000 claims abstract description 10
- 238000011068 loading method Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 14
- 239000002270 dispersing agent Substances 0.000 claims description 9
- 241001360088 Zymoseptoria tritici Species 0.000 claims description 6
- 239000002518 antifoaming agent Substances 0.000 claims description 6
- 238000012430 stability testing Methods 0.000 claims description 6
- -1 triethanolamine compound Chemical class 0.000 claims description 5
- 235000013339 cereals Nutrition 0.000 claims description 4
- 239000003906 humectant Substances 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 239000006254 rheological additive Substances 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 3
- 235000021015 bananas Nutrition 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000000080 wetting agent Substances 0.000 claims description 3
- PLLBRTOLHQQAQQ-UHFFFAOYSA-N 8-methylnonan-1-ol Chemical class CC(C)CCCCCCCO PLLBRTOLHQQAQQ-UHFFFAOYSA-N 0.000 claims description 2
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 241000184297 Pseudocercospora musae Species 0.000 claims description 2
- 235000021536 Sugar beet Nutrition 0.000 claims description 2
- 240000005561 Musa balbisiana Species 0.000 claims 1
- 241000415582 Puccinia striiformis f. sp. tritici Species 0.000 claims 1
- 238000003860 storage Methods 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000002156 mixing Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000003905 agrochemical Substances 0.000 description 4
- 230000000855 fungicidal effect Effects 0.000 description 4
- 239000000417 fungicide Substances 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 3
- 239000004495 emulsifiable concentrate Substances 0.000 description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 3
- 238000003801 milling Methods 0.000 description 3
- 241000234295 Musa Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000004562 water dispersible granule Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 244000291473 Musa acuminata Species 0.000 description 1
- 241000221300 Puccinia Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 101150002629 TAS1 gene Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- ZXQYGBMAQZUVMI-GCMPRSNUSA-N gamma-cyhalothrin Chemical compound CC1(C)[C@@H](\C=C(/Cl)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-GCMPRSNUSA-N 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000003921 particle size analysis Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
Definitions
- the invention relates to suspension concentrate formulations.
- the invention also relates to highly loaded epoxiconazole formulations incorporating the suspension concentrate aspect of the invention.
- a suspension concentrate is commonly used for formulations where one or more of the active ingredients is sparingly soluble in water or in organic solvents.
- An SC is a dispersion of small particles. Generally, the particles have a diameter in the range 0.4-12 pm. Particles may be attracted to each other, causing flocculation or settling, making the SC unstable.
- Epoxiconazole (1- ⁇ [3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2"yl]methyl ⁇ -lH-l,2,4-triazole) is a triazole fungicide that inhibits sterol biosynthesis in ascomycete, basidiomycete and deuteromycete fungi.
- Major use crops for epoxiconazole include cereals, bananas and sugar beet.
- Epoxiconazole is marketed as both a solo formulation and mixtures in a range of formulation types e.g. emulsifiable concentrates (EC), suspension concentrates (SC), suspoemulsions (SE) and water dispersible granules (WG).
- the surfactant component disclosed is a comb-graft copolymer surfactant having a poly-methacrylate backbone and pendant polyoxyethylene moieties attached to the backbone, such as that available as Atlox®4913.
- This component is combined with a second surfactant being either an ethoxylated or a propoxylated fatty alcohol surfactant comprising a fatty alcohol from 12 to 20 carbon atoms, such as that available as Antarox ®65A9P.
- the particle size distribution disclosed in 2020317060 was Dv (50): 2.07 to 2.14 and Dv (90): 6.01 to 6.10 pm.
- this invention provides a stable SC formulation which includes an active ingredient which has a particle size distribution in the range Dv (50): more than 4 and less than 5.5 pm and Dv (90): more than 8 and less than 9.8 pm.
- the particle size distribution may be that measurable prior to and/or after accelerated stability testing.
- the active ingredient may be chosen from a wide range, not limited to the agrichemical field. However, for the sake of illustration, the disclosure below will describe the invention as applicable to the agrichemical field.
- the formulation of the invention may include more than one active ingredient.
- the particle size distribution of the formulation of the invention is within acceptable limits for agricultural chemical products under the APVMA guidelines, referred to in more detail below.
- the acceptable limits are range Dv (50): less than 5.50 pm and Dv (90): less than 10.0 pm.
- the particle size distribution relevant to the invention may be regarded as a selection from the acceptable limits. Both the Dv (50) and the Dv (90) distributions are towards the upper end of the acceptable limits.
- Having a higher particle size distribution has the advantage of requiring less milling of the tech form of the active ingredient, which fine milling is currently required to achieve the initial fine particle size distribution required with existing formulations with of 400 g/L or more.
- first aspect of the invention is given in the second aspect of the invention - a highly loaded epoxiconazole formulation (see below). It is anticipated that the stable SC formulation of the invention is applicable to many other agricultural formulations.
- the stable SC formulation of the invention may include other components, including but not limited to dispersants, wetting agents, humectants, rheology modifiers, preservatives and antifoam agents. The choice of these may be made according to the characteristics of the active ingredient/s.
- the invention provides a stable, highly loaded epoxiconazole SC formulation, wherein the loading of epoxiconazole is more than 400 ai g/L and wherein the particle size distribution of epoxiconazole is in the range Dv (50): more than 4 and less than 5.5 pm and Dv (90): more than 8 and less than 9.8 pm.
- the formulation contains about 500 ai g/L or more of epoxiconazole.
- the formulation has a dispersant, being triethanolamine compound with polyoxyethylene tristyrylphenyl ether phosphate-based dispersant, available as Soprophor® FL, for example.
- a dispersant may be present in a quantity in excess of about 40 g/L or at least about 50 g/L.
- the formulation includes an ethoxylated isodecyl alcohol wetting agent with a short carbon chain length of 9 to 11 carbon atoms, such as available as Rhodasurf® 860/P, for example.
- This novel dispersant and surfactant combination provides a high quality alternative option to existing highly loaded epoxiconazole formulations and creates a more shelf stable formulation that is not prone to excessive particle size growth during long term storage.
- the epoxiconazole formulation may also include all or some of a humectant, a rheology modifier, a preservative and an antifoaming agent.
- suitable components are propylene glycol as humectant, Rheozan® as rheology modifier, Nipacide® BIT 20 as preservative and Gensil® 030 as antifoaming agent.
- the viscosity of the formulation is more than about 600 and at least 1000 cps.
- this embodiment may have nil visible retained material on a 38pm sieve after production and ⁇ 0.05% retained material after accelerated stability testing.
- This embodiment may also have improved pourability and ⁇ 2% residue and ⁇ 0.1% rinsed residue prior to and after accelerated stability testing.
- Epoxiconazole was sourced as in Table 2 below: Table 2: Active Ingredient
- Table 3 Details of the other components are in Table 3: Table 3: Other Components To prepare the formulation, by way of example, the following method and the sequence of operations were followed. The formulation was prepared in a batch process.
- the specimens remained in their containers and were stored in an air-conditioned facility at approximately 21 °C for the period prior to ambient temperature and elevated temperature storage.
- the sample designated for elevated temperature storage was placed into a thermostatically controlled oven (VWR Mini Incubator: SNR 0811V1169), heated to 54 ⁇ 2 °C, for a period of 14 days. At the end of this period, the sample was removed from the oven and placed into a desiccation chamber to allow cooling to ambience.
- VWR Mini Incubator SNR 0811V1169
- the remaining AD-AU-2006 SC formulation sample (Time Zero sample T01) was stored at air-conditioned ambient temperatures ( ⁇ 21 °C) in a locked cabinet for the duration of the elevated temperature storage period.
- AD-AU-2006 SC was prepared for low temperature stability testing by placing 100 mL of the formulated product into a 100 mL ASTM D96 graduated centrifuge tube and storing it in a refrigerated cabinet (Esatto Model EBF93W: SNR 5G386) at a temperature of 0 °C ⁇ 2 °C for a total of 7 days. Description of Methods Used
- the pH value of a 1% v/v dilution of the formulation is determined by means of a pH meter and electrode system.
- the viscosity of the formulation is measured in a standard measuring system using a Brookfield RV Viscometer.
- the suspension concentrate is allowed to stand for a definite time and the amount remaining in the container after a standardized pouring procedure is determined.
- the container is rinsed and the amount then remaining is determined.
- the method is broadly similar to that used to determine suspensibility (CIPAC MT 184), except that the preparation of the suspension of known concentration employs only one inversion and a 5 min standing time. The top 9/10 ⁇ 5 are the drawn off and the remaining l/10 th is then assayed chemically and the spontaneity of dispersion calculated.
- a suspension of known concentration in CIPAC Standard Water is prepared, placed in a prescribed measuring cylinder at a constant temperature, and allowed to remain undisturbed for a specific time (30 minutes). The top 9/10 ⁇ 5 are then drawn off and the remaining 1/10 ⁇ is then assayed chemically and the suspensibility calculated.
- a sample of the formulation is dispersed in water and the suspension formed is transferred to a sieve and washed. The amount of the material retained on the sieve is determined by drying and weighing.
- a representative sample of the formulation is dispersed in water, and then passed through the beam of a laser.
- the light scattered by the dispersed particles is measured by a multielement detector.
- Numerical values relating to the scattering pattern are calculated using an appropriate optical model and mathematical procedure to yield a volumetric particle size distribution.
- the sample is diluted in a measuring cylinder of standard dimensions which is inverted 30 times and the amount of foam created and remaining after certain times is measured.
- a sample is maintained at 0 ⁇ 2 °C for 7 days and the nature and quantity of any separated material retained following wet sieving through a 75 pm sieve is determined.
- Epoxiconazole content is determined by reversed phase high performance liquid chromatography using UV detection and external standardisation.
- a sample of the product in a container of the same material and construction to that of the marketed product is weighed and then maintained at 54 C for a period of 14 days. Any loss or gain in weight is recorded and the container examined, recording observations of any significant interaction with the formulation.
- Table 4 below shows analysis at Time Zero
- Table 5 shows the results of the accelerated stability sample
- Table 6 shows the result of the cold temperature stability test.
- the formulation was stable at low temperature.
- Trial 1 field trial was conducted at Bannockburn, Victoria, to evaluate AD-AU-2006 on stripe rust (Puccinia striiformisf.sp. tritici) in wheat cv. Trojan.
- AD-AU-2006 was applied twice at 65 and 125 mL/ha as a broadcast application in 125 L/ha volume at BBCH 33 and 39-41.
- Soprano® 500 was included as the standard fungicide at equivalent epoxiconazole doses.
- AD-AU-2006 provided similar control and yield improvement compared to the standard formulation, Soprano® 500.
- Table 7 Stripe rust severity at Bannockburn, Victoria.
- AD-AU-2006 was applied twice at 65 and 125 mL/ha as a broadcast application in 100 L/ha volume at BBCH 32 and 39.
- Soprano® 500 was included as the standard fungicide at equivalent epoxiconazole doses.
- AD-AU-2006 provided similar or superior control of Septoria tritici blotch compared to the standard formulation, Soprano® 500.
- AD-AU-2006 was applied six times at 75 and 150 mL/ha using a backpack mister.
- Soprano® was included as the standard fungicide at equivalent epoxiconazole doses.
- AD-AU-2006 and Soprano® were both tank mixed with Biopest® Oil at 5 L/ha.
- Solo Biopest® Oil at 5 L/ha was also applied for comparison
- AD-AU-2006 provided similar or superior control of Yellow Sigatoka compared to the standard formulation, Soprano®.
- the invention is able to provide an SC formulation containing an active ingredient by choosing large particle size distribution - a counter-intuitive concept to avoid or reduce flocculation - resulting in enhanced stability.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Dispersion Chemistry (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2022333660A AU2022333660A1 (en) | 2021-08-25 | 2022-08-25 | Improvement to suspension concentrate formulations |
CN202280069081.3A CN118102871A (zh) | 2021-08-25 | 2022-08-25 | 混悬浓缩制剂的改进 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021221775 | 2021-08-25 | ||
AU2021221775A AU2021221775A1 (en) | 2021-08-25 | 2021-08-25 | Improvement to Suspension Concentrate Formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023023813A1 true WO2023023813A1 (fr) | 2023-03-02 |
Family
ID=85322185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU2022/051041 WO2023023813A1 (fr) | 2021-08-25 | 2022-08-25 | Amélioration apportée à des formulations de concentré en suspension |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN118102871A (fr) |
AU (2) | AU2021221775A1 (fr) |
WO (1) | WO2023023813A1 (fr) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999048359A1 (fr) * | 1998-03-20 | 1999-09-30 | Dow Agrosciences Llc | Adjuvants pesticides |
EP1023832A1 (fr) * | 1999-01-29 | 2000-08-02 | American Cyanamid Company | Suspension aqueuse concentrée |
US20140364308A1 (en) * | 2011-12-27 | 2014-12-11 | Sumitomo Chemical Company, Limited | Microcapsule containing fungicidal active ingredient |
CN109526948A (zh) * | 2018-12-28 | 2019-03-29 | 苏州佳辉化工有限公司 | 一种杀菌剂及其制备方法 |
WO2021012012A1 (fr) * | 2019-07-24 | 2021-01-28 | Eureka! Agresearch Pty Ltd | Composition fongicide |
WO2021127126A1 (fr) * | 2019-12-19 | 2021-06-24 | Fmc Corporation | Compositions de concentré de suspension de diamide |
-
2021
- 2021-08-25 AU AU2021221775A patent/AU2021221775A1/en active Pending
-
2022
- 2022-08-25 AU AU2022333660A patent/AU2022333660A1/en active Pending
- 2022-08-25 WO PCT/AU2022/051041 patent/WO2023023813A1/fr active Application Filing
- 2022-08-25 CN CN202280069081.3A patent/CN118102871A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999048359A1 (fr) * | 1998-03-20 | 1999-09-30 | Dow Agrosciences Llc | Adjuvants pesticides |
EP1023832A1 (fr) * | 1999-01-29 | 2000-08-02 | American Cyanamid Company | Suspension aqueuse concentrée |
US20140364308A1 (en) * | 2011-12-27 | 2014-12-11 | Sumitomo Chemical Company, Limited | Microcapsule containing fungicidal active ingredient |
CN109526948A (zh) * | 2018-12-28 | 2019-03-29 | 苏州佳辉化工有限公司 | 一种杀菌剂及其制备方法 |
WO2021012012A1 (fr) * | 2019-07-24 | 2021-01-28 | Eureka! Agresearch Pty Ltd | Composition fongicide |
WO2021127126A1 (fr) * | 2019-12-19 | 2021-06-24 | Fmc Corporation | Compositions de concentré de suspension de diamide |
Also Published As
Publication number | Publication date |
---|---|
AU2022333660A1 (en) | 2024-04-04 |
AU2021221775A1 (en) | 2023-03-16 |
CN118102871A (zh) | 2024-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ2003576A3 (cs) | Pesticidní formulace | |
Farshad et al. | Effect of cholesterol-loaded-cyclodextrin in presence and absence of egg yolk during freezing step on quality of Markhoz buck’s spermatozoa | |
AU2022333660A1 (en) | Improvement to suspension concentrate formulations | |
CN114503990A (zh) | 一种含有阿维菌素与氟吡菌酰胺的悬浮剂 | |
US20220330545A1 (en) | Fungicide composition | |
EP1058114B1 (fr) | Méthode fournissant une uniformité indépendante du temps dans les essais du volume moyen des corpuscules | |
EP0813363B1 (fr) | Melanges fongicides | |
Wasilewski et al. | Effect of Talc Particle Size in Detergents for Fruits and Vegetables on the Ability to Remove Pesticide Residues | |
CN104604885B (zh) | 提高热贮悬浮率及稳定性的三唑酮可湿性粉剂、生产方法 | |
AU2021106990B4 (en) | Highly Loaded Florasulam Formulations | |
AU2021221818A1 (en) | Highly Loaded Fludioxonil Formulations | |
AU2021107329A4 (en) | Highly Loaded Paraquat Formulations | |
WO2022150881A1 (fr) | Formulation de triclopyr et de picloram sous forme de de concentré émulsionnable fortement chargé | |
AU2021107371B4 (en) | Highly Loaded Haloxyfop Formulations | |
WO2020121345A1 (fr) | Dispersion d'huile contenant du fluindapyr et son utilisation en tant que fongicide dans des cultures végétales | |
WO2020121346A1 (fr) | Suspoémulsion contenant du fluindapyr et son utilisation en tant que fongicide dans des plantes cultivées | |
AU2018282387A1 (en) | Suspension concentrate composition | |
RU2820219C2 (ru) | Фунгицидная композиция | |
WO2023023768A1 (fr) | Formulations de métalaxyl-m fortement chargées | |
El-Sayed et al. | Effect of hydrophilic-lipophilic balance (HLB) values of surfactant mixtures on the physicochemical properties of emulsifiable concentrate formulations of difenoconazole | |
WO1999029169A1 (fr) | Compositions pesticides | |
CN116391718B (zh) | 一种含烯肟菌胺的液体杀菌制剂及应用 | |
WO2020121347A1 (fr) | Suspension concentrée contenant du fluindapyr et son utilisation comme fongicide dans les plantes cultivées | |
CN116267959A (zh) | 一种啶氧菌酯·戊唑醇悬浮剂及其制备方法 | |
CN117617236A (zh) | 三唑类杀菌剂绿色乳油及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22859700 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2022333660 Country of ref document: AU Ref document number: 809291 Country of ref document: NZ Ref document number: AU2022333660 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022333660 Country of ref document: AU Date of ref document: 20220825 Kind code of ref document: A |